The Impact of Telemedicine in Enhancing Patient Self Care for Management of Chronic Kidney Diseases
试验速览
- 阶段
- 不适用
- 状态
- Not Applicable
- 发起方
- 入组人数
- 108
- 试验地点
- 1
- 主要终点
- Composite of Dialysis, death and hospitalization
研究概览
简要总结
Chronic Kidney Disease (CKD) is a significant public health issue associated with increased morbidity and progression to end-stage renal disease. Although treatment options are available, outcomes remain suboptimal due to limited disease awareness, inadequate self-care practices, and poor adherence to follow-up. Telemedicine has emerged as a promising approach to enhance patient education, engagement, and self-management, particularly in resource-limited settings. This randomized controlled trial is designed to assess the impact of a structured telemedicine-based self-management support program on the progression and morbidity of CKD. The study will be conducted at a tertiary care center in Nepal. A total of 108 eligible CKD patients will be randomly allocated into two groups: an intervention group receiving telemedicine-based education and follow-up, and a control group receiving standard care. Primary outcomes include changes in estimated glomerular filtration rate (eGFR), hospitalization events, dialysis initiation, and adherence to follow-up over a period of 6 months. Secondary outcomes include medication adherence, blood pressure control, and relevant laboratory parameters. The study aims to evaluate the effectiveness of telemedicine in enhancing patient-centered care and improving outcomes in CKD management
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)(—)
- 性别
- All
入选标准
- •Diagnosed as Chronic Kidney Diseases as per KDIGO criteria Patient willing to give consent and able to communicate verbally.
排除标准
- •Under dialysis (Hemodialysis and peritoneal dialysis) Patient who do not have mobile phone and internet acces Unwillingness to participate in the study.
结局指标
主要结局
Composite of Dialysis, death and hospitalization
时间窗: 3 and 6 months
Change in eGFR
时间窗: 3 and 6 months
次要结局
- Assessment of blood pressure, HbA1c and Hb(Adherence to medication)
研究者
Santosh Pokhrel
BP Koirala Institute of Health Sciences
